Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB SUN PHARMA DR. REDDYS LAB/
SUN PHARMA
 
P/E (TTM) x 17.6 37.0 47.6% View Chart
P/BV x 4.2 6.4 66.4% View Chart
Dividend Yield % 0.7 0.8 88.2%  

Financials

 DR. REDDYS LAB   SUN PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
SUN PHARMA
Mar-23
DR. REDDYS LAB/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6561,072 434.4%   
Low Rs3,788790 479.6%   
Sales per share (Unadj.) Rs1,481.4182.9 809.9%  
Earnings per share (Unadj.) Rs270.735.7 758.6%  
Cash flow per share (Unadj.) Rs345.746.2 748.0%  
Dividends per share (Unadj.) Rs40.0011.50 347.8%  
Avg Dividend yield %0.91.2 76.7%  
Book value per share (Unadj.) Rs1,389.6233.4 595.4%  
Shares outstanding (eoy) m166.532,399.34 6.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.85.1 56.0%   
Avg P/E ratio x15.626.1 59.8%  
P/CF ratio (eoy) x12.220.1 60.6%  
Price / Book Value ratio x3.04.0 76.2%  
Dividend payout %14.832.2 45.9%   
Avg Mkt Cap Rs m703,0392,233,361 31.5%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46682,960 56.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697438,857 56.2%  
Other income Rs m10,5558,199 128.7%   
Total revenues Rs m257,252447,055 57.5%   
Gross profit Rs m63,860112,900 56.6%  
Depreciation Rs m12,50225,294 49.4%   
Interest Rs m1,4281,720 83.0%   
Profit before tax Rs m60,48594,084 64.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4128,476 181.8%   
Profit after tax Rs m45,07385,608 52.7%  
Gross profit margin %25.925.7 100.6%  
Effective tax rate %25.59.0 282.8%   
Net profit margin %18.319.5 93.7%  
BALANCE SHEET DATA
Current assets Rs m203,161398,619 51.0%   
Current liabilities Rs m85,721199,064 43.1%   
Net working cap to sales %47.645.5 104.7%  
Current ratio x2.42.0 118.4%  
Inventory Days Days79147 53.9%  
Debtors Days Days10795 112.7%  
Net fixed assets Rs m112,638376,960 29.9%   
Share capital Rs m8332,399 34.7%   
"Free" reserves Rs m230,571557,555 41.4%   
Net worth Rs m231,404559,954 41.3%   
Long term debt Rs m1,2780-   
Total assets Rs m315,799775,794 40.7%  
Interest coverage x43.455.7 77.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 138.1%   
Return on assets %14.711.3 130.8%  
Return on equity %19.515.3 127.4%  
Return on capital %26.617.1 155.5%  
Exports to sales %52.20-   
Imports to sales %16.80-   
Exports (fob) Rs m128,803NA-   
Imports (cif) Rs m41,484NA-   
Fx inflow Rs m128,803154,053 83.6%   
Fx outflow Rs m41,48471,511 58.0%   
Net fx Rs m87,31982,541 105.8%   
CASH FLOW
From Operations Rs m58,87549,593 118.7%  
From Investments Rs m-41,373-79,437 52.1%  
From Financial Activity Rs m-26,86123,761 -113.0%  
Net Cashflow Rs m-9,0731,155 -785.7%  

Share Holding

Indian Promoters % 26.7 54.5 48.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 47.4 36.5 129.8%  
FIIs % 29.1 17.7 164.4%  
ADR/GDR % 15.4 0.0 -  
Free float % 58.0 45.5 127.4%  
Shareholders   255,500 631,392 40.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    SUPRIYA LIFESCIENCE     SANOFI INDIA    


More on Dr. Reddys vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Sun Pharma Share Price Performance

Period Dr. Reddys Sun Pharma S&P BSE HEALTHCARE
1-Day -0.47% -0.56% -0.51%
1-Month -1.46% 0.01% 1.44%
1-Year 29.73% 56.11% 52.10%
3-Year CAGR 3.61% 29.12% 12.94%
5-Year CAGR 17.09% 29.04% 21.48%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 8 Points Lower | Nifty Below 23,000 | Aegis logistics Rallies 12% Sensex Today Ends 8 Points Lower | Nifty Below 23,000 | Aegis logistics Rallies 12%(Closing)

After opening the day marginally higher, Indian share turned muted as the session progressed and ended the day flat.